Advances in the study of artemisinin and its derivatives for the treatment of rheumatic skeletal disorders, autoimmune inflammatory diseases, and autoimmune …
Z Long, W Xiang, W Xiao, Y Min, F Qu… - Frontiers in …, 2024 - frontiersin.org
Artemisinin and its derivatives are widely recognized as first-line treatments for malaria
worldwide. Recent studies have demonstrated that artemisinin-based antimalarial drugs …
worldwide. Recent studies have demonstrated that artemisinin-based antimalarial drugs …
Role of microRNAs in triple‑negative breast cancer and new therapeutic concepts
S Yang, D Li - Oncology Letters, 2024 - spandidos-publications.com
Breast cancer has surpassed lung cancer as the most prevalent malignancy affecting
women worldwide. Triple-negative breast cancer (TNBC) is the type of breast cancer with …
women worldwide. Triple-negative breast cancer (TNBC) is the type of breast cancer with …
Unraveling non-coding RNAs in breast cancer: mechanistic insights and therapeutic potential
M Shaikh, G Doshi - Medical Oncology, 2024 - Springer
Breast cancer remains a leading global health challenge requiring innovative, therapeutic
strategies to improve patient outcomes. This review explores the pivotal roles of non-coding …
strategies to improve patient outcomes. This review explores the pivotal roles of non-coding …
Interaction of ncRNAs and the PI3K/AKT/mTOR pathway: Implications for osteosarcoma
W Shao, Y Feng, J Huang, T Li, S Gao, Y Yang… - Open Life …, 2024 - degruyter.com
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and
adolescents, and is characterized by high heterogeneity, high malignancy, easy metastasis …
adolescents, and is characterized by high heterogeneity, high malignancy, easy metastasis …
KIFC3 promotes the progression of non–small cell lung cancer cells through the PI3K/Akt pathway
Y Mu, H Liu, A Luo, Q Zhang - Thoracic Cancer, 2024 - Wiley Online Library
Background Kinesin family member C3 (KIFC3), as reported, plays important roles in several
tumor types. Nevertheless, it is unknown whether KIFC3 has effects on non–small cell lung …
tumor types. Nevertheless, it is unknown whether KIFC3 has effects on non–small cell lung …
唾液酸转移酶ST6GalNAc 家族在肿瘤发生发展中作用的研究进展
马金聪， 张冬梅 - 大连医科大学学报, 2024 - journal.dmu.edu.cn
唾液酸转移酶ST6GalNAc 家族是催化唾液酸糖基化的重要酶类, 该家族酶负责在O-
链接的糖链和一些糖脂质上添加唾液酸, 形成α2, 6-连接的唾液酸化糖链. 近年来, ST6GalNAc …
链接的糖链和一些糖脂质上添加唾液酸, 形成α2, 6-连接的唾液酸化糖链. 近年来, ST6GalNAc …
Research progress on the role of ST6GalNAc sialyltransferase family in tumor development
MA Jincong, Z Dongmei - Journal of Dalian Medical University, 2024 - journal.dmu.edu.cn
The ST6GalNAc sialyltransferase family is a group of important enzymes that catalyze
sialylation, adding sialic acid in a α2, 6-linkage to O-linked glycans and certain glycolipids …
sialylation, adding sialic acid in a α2, 6-linkage to O-linked glycans and certain glycolipids …